Nektar Therapeutics (NKTR) Financials
Key financial figures for Nektar Therapeutics (Q1 2026).
- Revenue
- $11M
- Net Income
- -$45M
- EPS
- $-1.82
- Total Assets
- $763M
- Operating Cash Flow
- -$44M
Full income statement, balance sheet, and cash flow for Nektar Therapeutics on SentiSense.